• Development of a database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Positron Emission Tomography (PET) Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

    Condition:
    Alzheimer’s Disease (AD)
    Trial Name:
    Bio-Hermes-002

    Testing for: Non-interventional 

    Age:
    60-90
    Phase:
    Observational Study
Ask me something!
Chatbot